Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
James E Dentzer is Director at Curis. OQRO lists 11 transactions filed with the SEC under this name, the latest on Nov 11, 2026, each linked to the official Form 4.
Director
Disclosures on record
11
Companies involved
2
James E Dentzer has no open-market purchase on record since 2019. Sales in 4 of the 8 years since 2019.
James E Dentzer reported 0 open-market purchases and 8 sales since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2022 | — | $17K2×2 trades |
| 2021 | — | $58K2×2 trades |
| 2020 | — | $11K2×2 trades |
| 2019 | — | $6.2K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
ImunonIMNN
4 disclosures · Jan 2026 – Nov 2026
Nov 6, 202613Kdisclosed Nov 11
DetailsOfficial recordJul 31, 20266,934disclosed Aug 4
DetailsOfficial recordMay 22, 202611Kdisclosed May 27
DetailsOfficial recordJan 2, 20264,405disclosed Jan 6
DetailsOfficial recordCurisCRIS
7 disclosures · Mar 2026 – Jul 2026
Jul 7, 2026110Kdisclosed Jul 9
DetailsOfficial recordMar 20, 2026133Kdisclosed Mar 23
DetailsOfficial recordMar 20, 2026100disclosed Mar 23
DetailsOfficial recordMar 17, 2026100disclosed Mar 18
DetailsOfficial recordMar 17, 2026133Kdisclosed Mar 18
DetailsOfficial recordMar 17, 2026133Kdisclosed Mar 18
DetailsOfficial recordMar 17, 2026133Kdisclosed Mar 18
DetailsOfficial recordAs of the latest filing on , James E Dentzer reported holding 148,730 shares of Curis (CRIS), worth about $66K at the last close of $0 (Nov 13, 2026). Holdings are also on file at Imunon (IMNN); together they are worth about $88K.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Curis CRIS | 148,730 | 149K direct | $0 | $66K | Mar 20, 2026 |
| Imunon IMNN | 34,197 | 34K direct | $1 | $22K | Nov 6, 2026 |
Is this James E Dentzer’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
James E Dentzer reported 0 open-market purchases and 8 sales here, 2019 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Mar 20, 2026, James E Dentzer reported holding 148,730 shares of Curis (CRIS). At the last close of $0 on Nov 13, 2026, that is about $66K. This is the stake disclosed in filings, not a net worth.
James E Dentzer has no open-market purchase on record since 2019. Sales in 4 of the 8 years since 2019.
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2022.
Curis (CRIS), from 2019 to 2022: 0 purchases and 8 sales.